Hugo A. Tempelman

927 total citations
35 papers, 617 citations indexed

About

Hugo A. Tempelman is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Hugo A. Tempelman has authored 35 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 12 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Hugo A. Tempelman's work include HIV/AIDS Research and Interventions (19 papers), HIV Research and Treatment (12 papers) and HIV/AIDS drug development and treatment (10 papers). Hugo A. Tempelman is often cited by papers focused on HIV/AIDS Research and Interventions (19 papers), HIV Research and Treatment (12 papers) and HIV/AIDS drug development and treatment (10 papers). Hugo A. Tempelman collaborates with scholars based in Netherlands, South Africa and United States. Hugo A. Tempelman's co-authors include Annemarie M. J. Wensing, Andy I. M. Hoepelman, Diederick E. Grobbee, Lucas E. Hermans, Roos E. Barth, François Venter, W.L.J.M. Devillé, Roos E. Barth, Sergio Carmona and Douglas D. Richman and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Hugo A. Tempelman

31 papers receiving 606 citations

Peers

Countries citing papers authored by Hugo A. Tempelman

Since Specialization

Citations

This map shows the geographic impact of Hugo A. Tempelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo A. Tempelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo A. Tempelman more than expected).

Fields of papers citing papers by Hugo A. Tempelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo A. Tempelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo A. Tempelman. The network helps show where Hugo A. Tempelman may publish in the future.

Co-authorship network of co-authors of Hugo A. Tempelman

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo A. Tempelman. A scholar is included among the top collaborators of Hugo A. Tempelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo A. Tempelman. Hugo A. Tempelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Association Between HIV-Related Stigma, ART Adherence, and Cardiovascular Disease Risk in People Living With HIV 2025 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), Karine Scheuermaier, Alinda G. Vos, Roos E. Barth, W.L.J.M. Devillé, Roel A. Coutinho, (unknown), Diederick E. Grobbee, (unknown), Hugo A. Tempelman, Kerstin Klipstein‐Grobusch	0
2	The association of HIV status and depressive symptoms in the Ndlovu Cohort study 2025 ·Scientific Reports ·(unknown), Karine Scheuermaier, Hugo A. Tempelman, Roos E. Barth, W.L.J.M. Devillé, Roel A. Coutinho, Diederick E. Grobbee, François Venter, Alinda G. Vos, Kerstin Klipstein‐Grobusch	0
3	Trends in body mass index in the pre-dolutegravir period in South Africa 2024 ·Southern African Journal of HIV Medicine ·(unknown), Roos E. Barth, Hugo A. Tempelman, Kerstin Klipstein‐Grobusch, Diederick E. Grobbee, Karine Scheuermaier, (unknown), Alinda G. Vos	1
4	No Evidence for an Association of HIV and Antiviral Treatment With Changes in Framingham Cardiovascular Risk Score in the Ndlovu Cohort Study 2024 ·Journal of the American Heart Association ·(unknown), Alinda G. Vos, Daniel Boateng, Karine Scheuermaier, Hugo A. Tempelman, Roos E. Barth, W.L.J.M. Devillé, Roel A. Coutinho, François Venter, Diederick E. Grobbee, Kerstin Klipstein‐Grobusch	2
5	Evaluation of the Seegene Allplex™ RV master assay for one-step simultaneous detection of eight respiratory viruses in nasopharyngeal specimens 2024 ·Journal of Virological Methods ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hugo A. Tempelman, (unknown)	1
6	Predictors of Treatment Adherence and Virological Failure Among People Living with HIV Receiving Antiretroviral Therapy in a South African Rural Community: A Sub-study of the ITREMA Randomised Clinical Trial 2023 ·AIDS and Behavior ·(unknown), Annemarie M. J. Wensing, Samanta Tresha Lalla‐Edward, John de Wit, François Venter, Hugo A. Tempelman, Lucas E. Hermans	4
7	Prevalence, incidence and recurrence of sexually transmitted infections in HIV‐negative adult women in a rural South African setting 2023 ·Tropical Medicine & International Health ·(unknown), (unknown), (unknown), (unknown), (unknown), Hugo A. Tempelman, Annemarie M. J. Wensing, Lucas E. Hermans	0
8	Unmasking a silent killer: Prevalence of diagnosed and undiagnosed diabetes mellitus among people living with HIV in rural South Africa 2023 ·Tropical Medicine & International Health ·(unknown), (unknown), (unknown), (unknown), Hugo A. Tempelman, Kerstin Klipstein‐Grobusch, Lucas E. Hermans, Karine Scheuermaier, W.L.J.M. Devillé, Alinda G. Vos	6
9	Comparative performance of cardiovascular risk prediction models in people living with HIV 2022 ·Southern African Journal of HIV Medicine ·(unknown), Alinda G. Vos, Johanna AAG Damen, Roos E. Barth, Hugo A. Tempelman, Diederick E. Grobbee, Karine Scheuermaier, François Venter, Kerstin Klipstein‐Grobusch	2
10	Evaluation of a commercial SARS-CoV-2 multiplex PCR genotyping assay for variant identification in resource-scarce settings 2022 ·PLoS ONE ·(unknown), Zinhle Makatini, (unknown), (unknown), (unknown), (unknown), Monique Nijhuis, Annemarie M. J. Wensing, Hugo A. Tempelman	13
11	A randomized study of intensified antiretroviral treatment monitoring versus standard-of-care for prevention of drug resistance and antiretroviral treatment switch 2022 ·AIDS ·Lucas E. Hermans, Rob ter Heine, Rob Schuurman, Hugo A. Tempelman, David M. Burger, Sigrid C. J. M. Vervoort, W.L.J.M. Devillé, Dorien de Jong, François Venter, Monique Nijhuis, Annemarie M. J. Wensing	1
12	Sharp increase in influenza A infections in Limpopo: A call for increased influenza vaccinations 2021 ·South African Medical Journal ·(unknown), Zinhle Makatini, (unknown), Hugo A. Tempelman	2
13	Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study 2020 ·PLoS Medicine ·Lucas E. Hermans, Sergio Carmona, Monique Nijhuis, Hugo A. Tempelman, Douglas D. Richman, Michelle Moorhouse, Diederick E. Grobbee, François Venter, Annemarie M. J. Wensing	36
14	Ideal Cardiovascular Health Index and Its Determinants in a Rural South African Population 2020 ·Global Heart ·(unknown), Alinda G. Vos, Noortje G. Godijk, Karine Scheuermaier, W.L.J.M. Devillé, Hugo A. Tempelman, R A Coutinho, François Venter, Diederick E. Grobbee, Kerstin Klipstein‐Grobusch	14
15	The association between HIV infection and pulmonary function in a rural African population 2019 ·PLoS ONE ·Meri R.J. Varkila, Alinda G. Vos, Roos E. Barth, Hugo A. Tempelman, W.L.J.M. Devillé, Roel A. Coutinho, Diederick E. Grobbee, Kerstin Klipstein‐Grobusch	14
16	Hypertension in a rural community in South Africa: what they know, what they think they know and what they recommend 2019 ·BMC Public Health ·Vita W. Jongen, Samanta Tresha Lalla‐Edward, Alinda G. Vos, Noortje G. Godijk, Hugo A. Tempelman, Diederick E. Grobbee, W.L.J.M. Devillé, Kerstin Klipstein‐Grobusch	26
17	Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study 2017 ·The Lancet Infectious Diseases ·Lucas E. Hermans, Michelle Moorhouse, Sergio Carmona, Diederick E. Grobbee, L. Marije Hofstra, Douglas D. Richman, Hugo A. Tempelman, François Venter, Annemarie M. J. Wensing	112
18	Albuminuria Is Associated with Traditional Cardiovascular Risk Factors and Viral Load in HIV-Infected Patients in Rural South Africa 2015 ·PLoS ONE ·G. Emerens Wensink, Annelot F. Schoffelen, Hugo A. Tempelman, Maarten B. Rookmaaker, Andy I. M. Hoepelman, Roos E. Barth	16
19	Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa 2011 ·Journal of Medical Virology ·Roos E. Barth, (unknown), Hugo A. Tempelman, Tania Mudrikova, Annemarie M. J. Wensing, Andy I. M. Hoepelman	28
20	Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa 2008 ·AIDS ·Roos E. Barth, Annemarie M. J. Wensing, Hugo A. Tempelman, (unknown), Rob Schuurman, Andy I. M. Hoepelman	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact